Drug:
Reaction: THERAPY INTERRUPTED
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940305 |
US |
66 | 2 |
Therapy interrupted, Product distribution issue, |
||||
MAVACAMTEN, MAVACAMTEN, |
||||
| 2 | 26940585 |
US |
||
Malaise, Therapy interrupted, Product availability issue, |
||||
THEOPHYLLINE ANHYDROUS, |
||||
| 3 | 26940606 |
CA |
46 | |
Surgery, Condition aggravated, Abscess limb, Insurance issue, Treatment delayed, Therapy interrupted, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 4 | 26940665 |
US |
1 | |
Injection site reaction, Therapy interrupted, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 5 | 26940786 |
US |
2 | |
Therapy interrupted, Blood pressure abnormal, Pulmonary oedema, |
||||
ACALABRUTINIB, FUROSEMIDE, NIFEDIPINE, |
||||
| 6 | 26940793 |
US |
2 | |
Neuralgia, Weight increased, Fluid retention, Adverse event, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 7 | 26941430 |
US |
70 | 2 |
Coma, Intestinal perforation, Liver transplant, Cardiac disorder, Gait disturbance, Chest pain, Hepatic steatosis, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 8 | 26941435 |
US |
50 | 2 |
Pericarditis, Drug dose omission by device, Device difficult to use, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 9 | 26941795 |
CA |
47 | |
Haematochezia, Abdominal pain, Product distribution issue, Therapy interrupted, Inappropriate schedule of product administration, Therapeutic response shortened, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, MESALAMINE, MESALAMINE, |
||||
| 10 | 26941811 |
US |
1 | |
Therapy interrupted, Inappropriate schedule of product administration, Nasopharyngitis, COVID-19, |
||||
TILDRAKIZUMAB-ASMN, |
||||
| 11 | 26941904 |
AE |
2 | |
Rheumatoid arthritis, Product dose omission issue, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 12 | 26941973 |
US |
42 | 2 |
Rheumatoid arthritis, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 13 | 26942723 |
AU |
12 | 2 |
Bone giant cell tumour benign, Hypercalcaemia, Therapy interrupted, |
||||
DENOSUMAB, |
||||
| 14 | 26942952 |
US |
45 | |
Muscle tightness, Back pain, Therapy interrupted, Overdose, |
||||
BUROSUMAB, BUROSUMAB, |
||||
| 15 | 26943348 |
US |
1 | |
Ankylosing spondylitis, Product availability issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 16 | 26943975 |
US |
2 | |
Productive cough, Off label use, Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 17 | 26944026 |
US |
73 | 2 |
Psoriatic arthropathy, Alopecia, Oedema, Arthralgia, Urinary tract infection, Therapy interrupted, Psoriasis, Nail disorder, Otorrhoea, Dermatitis, Drug ineffective, Pruritus, Dry skin, Chills, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 18 | 26944413 |
GB |
72 | |
Cataract, Fatigue, Therapy interrupted, Product prescribing issue, |
||||
INFLIXIMAB-DYYB, |
||||
| 19 | 26944422 |
US |
42 | 2 |
Seizure, Therapy interrupted, Fall, Product use issue, Overdose, Insurance issue, |
||||
BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, |
||||
| 20 | 26944429 |
GB |
1 | |
Psoriatic arthropathy, Product prescribing issue, Product availability issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 21 | 26944604 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, Loss of personal independence in daily activities, Inability to afford medication, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 22 | 26944645 |
CA |
74 | 2 |
Cystitis, Drug ineffective, Insurance issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 23 | 26944773 |
US |
52 | 1 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 24 | 26944809 |
US |
48 | 1 |
Hospitalisation, Liver disorder, Ammonia increased, Therapy interrupted, |
||||
RIFAXIMIN, |
||||
| 25 | 26945366 |
US |
63 | 1 |
Therapy interrupted, Product distribution issue, |
||||
LENALIDOMIDE, |
||||
| 26 | 26945588 |
US |
2 | |
Feeling abnormal, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 27 | 26945630 |
US |
1 | |
Product use in unapproved indication, Therapy interrupted, |
||||
ABALOPARATIDE, CARVEDILOL, CELECOXIB, MONTELUKAST, RIMEGEPANT SULFATE, RIZATRIPTAN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 28 | 26945734 |
US |
2 | |
Laboratory test abnormal, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 29 | 26945759 |
US |
75 | 2 |
Product distribution issue, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 30 | 26945770 |
US |
73 | 2 |
Insomnia, Palpitations, Pruritus, Intentional product misuse, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 31 | 26946002 |
US |
2 | |
Ageusia, Illness, Injection site pruritus, Drug hypersensitivity, Product supply issue, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, CYCLOSPORINE, SIMVASTATIN, CYCLOBENZAPRINE, HYDROCHLOROTHIAZIDE, |
||||
| 32 | 26946127 |
US |
59 | |
Generalised tonic-clonic seizure, Seizure, Concussion, Fracture, Fall, Head injury, Generalised tonic-clonic seizure, Seizure, Product dose omission issue, Incorrect dose administered, Therapy interrupted, Off label use, |
||||
CENOBAMATE, CENOBAMATE, CENOBAMATE, OXCARBAZEPINE, DIVALPROEX SODIUM, |
||||
| 33 | 26946400 |
US |
77 | 2 |
Hospitalisation, Gait disturbance, Therapy interrupted, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 34 | 26946453 |
US |
2 | |
Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 35 | 26946721 |
US |
54 | 2 |
Anxiety, Frustration tolerance decreased, Influenza, Feeling abnormal, Palpitations, Fatigue, Malaise, Pain in extremity, Arthralgia, Incorrect dose administered, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, LORAZEPAM, |
||||
| 36 | 26946963 |
US |
2 | |
Therapy interrupted, |
||||
ABALOPARATIDE, CALCIUM, |
||||
| 37 | 26946970 |
US |
68 | 2 |
Spinal fusion surgery, Blood pressure decreased, Weight increased, Fall, Hand fracture, Therapy interrupted, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, VITAMIN C, ERGOCALCIFEROL, MELATONIN, FOLIC ACID, CARVEDILOL, VALSARTAN, VALSARTAN ORAL, METHOTREXATE, METHOTREXATE SODIUM, HYDROCHLOROTHIAZIDE, |
||||
| 38 | 26947023 |
US |
74 | 2 |
Therapy interrupted, Liquid product physical issue, Drug effect less than expected, |
||||
ABALOPARATIDE, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FAMOTIDINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, HYDROCHLOROTHIAZIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FISH OIL, ASCORBIC ACID, BIOTIN, |
||||
| 39 | 26947025 |
US |
52 | 1 |
Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 40 | 26947156 |
US |
2 | |
Hospitalisation, Bone density abnormal, Fall, Back pain, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 41 | 26947414 |
US |
2 | |
Dysstasia, Pain, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 42 | 26947703 |
56 | ||
Illness, Therapy interrupted, |
||||
LENIOLISIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, CAPLACIZUMAB, CEFTRIAXONE SODIUM, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, FERROUS SULFATE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, THIAMINE HYDROCHLORIDE, |
||||
| 43 | 26947704 |
US |
61 | 2 |
Surgery, Swelling face, Eye swelling, Head discomfort, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, CELECOXIB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 44 | 26947789 |
US |
2 | |
Nausea, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ERGOCALCIFEROL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, |
||||
| 45 | 26947832 |
US |
2 | |
Influenza like illness, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 46 | 26948004 |
US |
74 | 2 |
Feeling cold, Brain fog, Tremor, Dizziness postural, Anxiety, Blood pressure fluctuation, Weight decreased, Blood pressure decreased, Abdominal discomfort, Decreased appetite, Feeling abnormal, Blood pressure increased, Dizziness, Heart rate increased, Constipation, Headache, Vertigo, Fatigue, Nausea, Therapy interrupted, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, EVOLOCUMAB, |
||||
| 47 | 26948198 |
US |
59 | 2 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 48 | 26948265 |
US |
2 | |
Therapy interrupted, Product supply issue, |
||||
ABALOPARATIDE, FLUTICASONE PROPIONATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PHYTONADIONE, |
||||
| 49 | 26951656 |
83 | 2 | |
Fluid retention, Renal disorder, Peripheral swelling, Therapy interrupted, Sciatica, |
||||
MAVACAMTEN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 50 | 26951798 |
1 | ||
Hospitalisation, Therapy interrupted, |
||||
MOMELOTINIB, |
||||
| 51 | 26952037 |
74 | 1 | |
Infection, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 52 | 26952040 |
38 | 2 | |
Abdominal pain, Vomiting, Impaired gastric emptying, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 53 | 26952117 |
70 | 2 | |
Metabolic encephalopathy, Pneumonia, Sepsis, Therapy interrupted, |
||||
MAVACAMTEN, |
||||
| 54 | 26952126 |
68 | 1 | |
Therapy interrupted, Hepatic enzyme increased, Hepatic cirrhosis, Abdominal distension, Confusional state, Wound, Faeces discoloured, Inguinal hernia, Septic shock, Peritonitis bacterial, Intestinal perforation, |
||||
BEVACIZUMAB-AWWB, ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 55 | 26952197 |
66 | 1 | |
Therapy interrupted, Infection, |
||||
VENETOCLAX, |
||||
| 56 | 26952200 |
65 | 2 | |
Therapy interrupted, Asthma, Infection, Product use issue, |
||||
TEZEPELUMAB-EKKO, |
||||
| 57 | 26934085 |
CA |
40 | |
Crohn^s disease, Malaise, Diarrhoea, Nausea, Abscess, Off label use, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, SERTRALINE, ARIPIPRAZOLE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 58 | 26934384 |
US |
2 | |
Therapy interrupted, Cyst, Pain in extremity, Intercepted product storage error, Device difficult to use, Drug dose omission by device, Arthralgia, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 59 | 26934420 |
CO |
66 | 2 |
Walking disability, Fall, Bronchitis, Gastritis, Injection site bruising, Sleep apnoea syndrome, Spinal pain, Pain in extremity, Dysstasia, Discouragement, Therapy interrupted, Illness, Ill-defined disorder, Pain, Amnesia, Injection site pain, Injection site haematoma, |
||||
ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, CALCIUM, |
||||
| 60 | 26934667 |
CA |
51 | |
Road traffic accident, Product dose omission issue, Therapy interrupted, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 61 | 26934740 |
US |
2 | |
Spinal fracture, Therapy interrupted, |
||||
DENOSUMAB, |
||||
| 62 | 26934802 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 63 | 26934803 |
AR |
43 | 1 |
Myocarditis, Adverse reaction, Rash erythematous, Dermatitis acneiform, Therapy interrupted, |
||||
PANITUMUMAB, PANITUMUMAB, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 64 | 26935033 |
US |
85 | |
Hospitalisation, Therapy interrupted, Pain, Pain, Pain, Flank pain, Nausea, Flank pain, Nausea, Vomiting, Incorrect dose administered, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 65 | 26935386 |
US |
2 | |
Hereditary angioedema, Hereditary angioedema, Insurance issue, Therapy interrupted, |
||||
GARADACIMAB, GARADACIMAB, |
||||
| 66 | 26935492 |
AU |
10 | 1 |
Bone giant cell tumour benign, Hypercalcaemia, Off label use, Therapy interrupted, |
||||
DENOSUMAB, |
||||
| 67 | 26935802 |
US |
2 | |
Endometrial cancer, Inappropriate schedule of product administration, Psoriasis, Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 68 | 26935813 |
BR |
40 | 1 |
Intestinal resection, Adverse reaction, Therapy interrupted, Frequent bowel movements, Diarrhoea, Groin pain, Back pain, Pain in extremity, Acne, Pruritus, Gastrointestinal disorder, |
||||
PANITUMUMAB, |
||||
| 69 | 26935827 |
US |
54 | 2 |
Myocardial infarction, Rheumatoid arthritis, Psoriasis, Depression, Off label use, Illness, Cardiac disorder, Skin laceration, Therapy interrupted, Stress, Product prescribing error, Brain fog, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 70 | 26935858 |
US |
2 | |
Psoriatic arthropathy, Maternal exposure during pregnancy, Therapy interrupted, Product availability issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 71 | 26935869 |
US |
1 | |
Psoriatic arthropathy, Therapy interrupted, |
||||
ETANERCEPT, PREDNISONE, |
||||
| 72 | 26936065 |
US |
59 | 1 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 73 | 26936198 |
CO |
67 | 2 |
Thrombocytopenia, Therapy interrupted, |
||||
ROMIPLOSTIM, |
||||
| 74 | 26936205 |
US |
2 | |
Meningitis aseptic, Therapy interrupted, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 75 | 26936416 |
US |
70 | 1 |
Psoriatic arthropathy, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 76 | 26936609 |
US |
79 | 2 |
Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 77 | 26936790 |
US |
2 | |
Psoriatic arthropathy, Rheumatoid arthritis, Product availability issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 78 | 26937060 |
CA |
33 | |
Chest pain, Pneumonia, Pyrexia, Cough, Drug effect less than expected, Therapy interrupted, Off label use, Intentional dose omission, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST, |
||||
| 79 | 26937212 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 80 | 26937428 |
US |
76 | 1 |
Product packaging quantity issue, Therapy interrupted, |
||||
| 81 | 26937769 |
US |
1 | |
Therapy interrupted, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 82 | 26938301 |
US |
75 | 2 |
Asthma, Drug interaction, Loss of therapeutic response, Therapy interrupted, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 83 | 26938536 |
US |
71 | 2 |
Hospitalisation, Liver disorder, Condition aggravated, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, |
||||
| 84 | 26938563 |
2 | ||
Lethargy, Brain fog, Dyspnoea, Therapy interrupted, |
||||
PALBOCICLIB, |
||||
| 85 | 26938609 |
US |
2 | |
Therapy interrupted, |
||||
BRENSOCATIB, MELATONIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 86 | 26938610 |
US |
2 | |
Condition aggravated, Therapy interrupted, |
||||
BRENSOCATIB, |
||||
| 87 | 26938830 |
US |
2 | |
Therapy interrupted, Fatigue, Dizziness, Vertigo, |
||||
ABALOPARATIDE, |
||||
| 88 | 26938844 |
US |
63 | 2 |
Dizziness, Headache, Fatigue, Intentional product misuse, Therapy interrupted, Product quality issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ZINC OXIDE, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT, ZINC OXIDE OINTMENT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN, ZINC OXIDE 20%, SKIN PROTECTANT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, MAGNESIUM OXIDE, CALCIUM, ERGOCALCIFEROL, FISH OIL, VITAMIN C, NETARSUDIL, BIMATOPROST, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, |
||||
| 89 | 26938875 |
US |
73 | 1 |
Product administered at inappropriate site, Product use complaint, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, GABAPENTIN, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TERIPARATIDE, |
||||
| 90 | 26938879 |
US |
2 | |
Injection site bruising, Therapy interrupted, Product availability issue, |
||||
ABALOPARATIDE, |
||||
| 91 | 26938904 |
US |
1 | |
Therapy interrupted, Injection site bruising, |
||||
ABALOPARATIDE, |
||||
| 92 | 26938905 |
US |
70 | 2 |
Dizziness, Therapy interrupted, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOLTERODINE, |
||||
| 93 | 26938952 |
US |
72 | 2 |
Injection site bruising, Product dose omission issue, Therapeutic product effect incomplete, Therapy interrupted, Product use complaint, Device malfunction, Product use issue, Device defective, |
||||
ABALOPARATIDE, |
||||
| 94 | 26938958 |
US |
79 | 1 |
Therapy interrupted, Intentional dose omission, Product use complaint, Needle issue, Needle issue, Drug dose omission by device, Drug ineffective, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 95 | 26938976 |
US |
2 | |
Dizziness, Malaise, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 96 | 26939041 |
US |
69 | 2 |
Therapy interrupted, Incorrect product administration duration, Product dose omission issue, |
||||
ABALOPARATIDE, TIRZEPATIDE, |
||||
| 97 | 26939165 |
US |
2 | |
Therapy interrupted, Drug dose omission by device, Device failure, Device issue, Device failure, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, PIROXICAM, |
||||
| 98 | 26939187 |
US |
2 | |
Influenza, Spinal pain, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 99 | 26939721 |
US |
72 | 2 |
Headache, Therapy interrupted, Intentional product misuse, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 100 | 26943067 |
65 | 2 | |
Therapy interrupted, Atrial fibrillation, Sepsis, Hepatic enzyme increased, |
||||
AVACOPAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
